Shared Decision-Making Concerning Anal Cancer Screening in Persons With Human Immunodeficiency Virus
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Edward R Cachay und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Owen Clinic, University of California-San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Anus Neoplasms, Carcinoma in Situ, HIV Infections, Squamous Intraepithelial Lesions. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, University of California.
Abstract (Originalsprache)
Background
Anal high-grade squamous intraepithelial lesion (aHSIL) is the immediate precursor of anal cancer. Anal cytology is a recommended screening test to identify aHSIL among people with human immunodeficiency virus (HIV; PWH). Heterogeneity of risk for invasive anal cancer among PWH suggests the value of a shared decision-making framework regarding screening.
Methods
Using a longitudinal HIV cohort with a comprehensive anal cancer screening program, we estimated the adjusted probabilities of having aHSIL on the first anal cytology. We used logistic regression models with inverse probability weighting to account for differential screening in the cohort and to construct a predicted probability nomogram for aHSIL. Sensitivity analysis was performed to estimate aHSIL prevalence corrected for misclassification bias.
Results
Of 8139 PWH under care between 2007 and 2020, 4105 (49.8%) underwent at least 1 anal cytology test. First-time cytology aHSIL was present in 502 (12.2%) PWH. The adjusted probability of having aHSIL varied from 5% to 18% depending on patient characteristics. Prespecified factors in the aHSIL prediction model included nadir CD4 cell count, ethnicity, race, age, sex, gender identity, and HIV risk factors. The ability of the model to discriminate cytological aHSIL was modest, with an area under the curve of 0.63 (95% confidence interval, .60–.65).
Conclusions
PWH are at increased risk for aHSIL and invasive anal cancer. Risk, however, varies by patient characteristics. Individual risk factor profiles predictive of aHSIL can be modeled and operationalized as nomograms to facilitate shared decision-making conversations concerning anal cancer screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Owen Clinic, University of California-San Diego, San Diego, California, USA.
- Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California-San Diego, San Diego, California, USA.
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- University of California
- Pacific AIDS Education and Training Center
- NIH
Zitieren
APA
Cachay, E. R., Gilbert, T., Deiss, R., & Mathews, W. C. (2023). Shared Decision-Making Concerning Anal Cancer Screening in Persons With Human Immunodeficiency Virus. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac491
Vancouver
Cachay ER, Gilbert T, Deiss R, Mathews WC. Shared Decision-Making Concerning Anal Cancer Screening in Persons With Human Immunodeficiency Virus. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac491
BibTeX
@article{Cachay2023,
author = {Cachay, Edward R and Gilbert, Tari and Deiss, Robert and Mathews, Wm Christopher},
title = {Shared Decision-Making Concerning Anal Cancer Screening in Persons With Human Immunodeficiency Virus},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac491}
}
EUVIMED